Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report

Background Neuropsychiatric symptoms associated with long COVID are a growing concern. A proposed pathophysiology is increased inflammatory mediators. There is evidence that typical serotonergic antidepressants have limited efficacy in the presence of inflammation. Although ketamine has shown promis...

Full description

Saved in:
Bibliographic Details
Main Authors: Baldwin Kaitlyn PharmD (Author), Wanson Annabelle MD, FRCPC (Author), Gilecki Lee-Anne MD, FRCPC (Author), Dalton Courtney BSP (Author), Peters Evyn MD, FRCPC (Author), Halpape Katelyn BSP, ACPR, PharmD, BCPP (Author)
Format: Book
Published: American Association of Psychiatric Pharmacists, 2023-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available